Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 50% ± 13% | |
| lung | 18 studies | 47% ± 18% | |
| intestine | 8 studies | 32% ± 21% | |
| kidney | 8 studies | 33% ± 15% | |
| placenta | 5 studies | 27% ± 7% | |
| lymph node | 5 studies | 35% ± 27% | |
| bone marrow | 4 studies | 40% ± 13% | |
| uterus | 4 studies | 54% ± 15% | |
| prostate | 4 studies | 39% ± 16% | |
| breast | 4 studies | 47% ± 8% | |
| liver | 4 studies | 36% ± 9% | |
| adrenal gland | 3 studies | 28% ± 8% | |
| esophagus | 3 studies | 59% ± 26% | |
| brain | 3 studies | 39% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4531.77 | 245 / 245 | 99% | 348.74 | 498 / 502 |
| skin | 100% | 12546.72 | 1809 / 1809 | 99% | 456.64 | 467 / 472 |
| uterus | 100% | 3619.35 | 170 / 170 | 99% | 405.91 | 454 / 459 |
| stomach | 99% | 5672.73 | 357 / 359 | 98% | 333.31 | 281 / 286 |
| bladder | 100% | 4620.81 | 21 / 21 | 98% | 457.97 | 492 / 504 |
| lung | 99% | 6574.03 | 574 / 578 | 98% | 287.76 | 1127 / 1155 |
| breast | 100% | 7160.89 | 459 / 459 | 96% | 245.18 | 1078 / 1118 |
| esophagus | 98% | 9618.02 | 1411 / 1445 | 98% | 234.71 | 180 / 183 |
| intestine | 97% | 4581.94 | 936 / 966 | 99% | 414.93 | 521 / 527 |
| kidney | 98% | 3768.62 | 87 / 89 | 98% | 186.42 | 879 / 901 |
| thymus | 95% | 2852.13 | 620 / 653 | 97% | 191.57 | 588 / 605 |
| ovary | 84% | 2202.16 | 151 / 180 | 98% | 247.05 | 421 / 430 |
| pancreas | 63% | 1443.50 | 206 / 328 | 94% | 430.17 | 168 / 178 |
| adrenal gland | 100% | 5431.78 | 258 / 258 | 53% | 77.71 | 122 / 230 |
| liver | 43% | 994.70 | 97 / 226 | 65% | 115.18 | 262 / 406 |
| adipose | 100% | 7954.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 416.03 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 400.44 | 29 / 29 |
| spleen | 100% | 7042.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 547.73 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 751.43 | 1 / 1 |
| peripheral blood | 99% | 26367.80 | 921 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 5901.79 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| brain | 23% | 472.82 | 603 / 2642 | 73% | 103.97 | 516 / 705 |
| heart | 94% | 3303.71 | 807 / 861 | 0% | 0 | 0 / 0 |
| muscle | 58% | 1196.05 | 464 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0033574 | Biological process | response to testosterone |
| GO_0051901 | Biological process | positive regulation of mitochondrial depolarization |
| GO_0010042 | Biological process | response to manganese ion |
| GO_0071476 | Biological process | cellular hypotonic response |
| GO_0006821 | Biological process | chloride transport |
| GO_0032374 | Biological process | regulation of cholesterol transport |
| GO_0015918 | Biological process | sterol transport |
| GO_0060252 | Biological process | positive regulation of glial cell proliferation |
| GO_0060242 | Biological process | contact inhibition |
| GO_0071294 | Biological process | cellular response to zinc ion |
| GO_2000853 | Biological process | negative regulation of corticosterone secretion |
| GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
| GO_0006783 | Biological process | heme biosynthetic process |
| GO_0014012 | Biological process | peripheral nervous system axon regeneration |
| GO_0010266 | Biological process | response to vitamin B1 |
| GO_0062100 | Biological process | positive regulation of programmed necrotic cell death |
| GO_0050810 | Biological process | regulation of steroid biosynthetic process |
| GO_0042632 | Biological process | cholesterol homeostasis |
| GO_0006700 | Biological process | C21-steroid hormone biosynthetic process |
| GO_1905144 | Biological process | response to acetylcholine |
| GO_1901525 | Biological process | negative regulation of mitophagy |
| GO_0006820 | Biological process | monoatomic anion transport |
| GO_0072656 | Biological process | maintenance of protein location in mitochondrion |
| GO_0060253 | Biological process | negative regulation of glial cell proliferation |
| GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
| GO_0030325 | Biological process | adrenal gland development |
| GO_1903579 | Biological process | negative regulation of ATP metabolic process |
| GO_0008347 | Biological process | glial cell migration |
| GO_0051928 | Biological process | positive regulation of calcium ion transport |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0048266 | Biological process | behavioral response to pain |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
| GO_0006626 | Biological process | protein targeting to mitochondrion |
| GO_0008202 | Biological process | steroid metabolic process |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0032570 | Biological process | response to progesterone |
| GO_0042127 | Biological process | regulation of cell population proliferation |
| GO_0031397 | Biological process | negative regulation of protein ubiquitination |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0015485 | Molecular function | cholesterol binding |
| GO_0120020 | Molecular function | cholesterol transfer activity |
| GO_0005497 | Molecular function | androgen binding |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008503 | Molecular function | benzodiazepine receptor activity |
| Gene name | TSPO |
| Protein name | Putative peripheral benzodiazepine receptor-related protein Translocator protein (Peripheral-type benzodiazepine receptor) Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) |
| Synonyms | MBR BZRP PBRS |
| Description | FUNCTION: Can bind protoporphyrin IX and may play a role in the transport of porphyrins and heme (By similarity). Promotes the transport of cholesterol across mitochondrial membranes and may play a role in lipid metabolism , but its precise physiological role is controversial. It is apparently not required for steroid hormone biosynthesis. Was initially identified as peripheral-type benzodiazepine receptor; can also bind isoquinoline carboxamides . . |
| Accessions | J3QLD3 P30536 ENST00000329563.8 [P30536-1] B1AH87 B1AH88 ENST00000337554.8 [P30536-1] ENST00000396265.4 [P30536-1] ENST00000583777.5 ENST00000428336.5 |